AINeutralGoogle DeepMind Blog · May 165/10
🧠
Uniting biological toolkits for a new approach to ALS
Boston Children's Hospital and MIT researchers are collaborating to develop RNA-based treatments for ALS (amyotrophic lateral sclerosis), combining their biological expertise to advance therapeutic approaches. This interdisciplinary partnership leverages complementary research capabilities to address a neurodegenerative disease with limited current treatment options.
